The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Category: Multiple Sclerosis Research
Tolebrutinib outcomes not as hoped for progressive MS
The post Tolebrutinib outcomes not as hoped for progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au
New relapsing remitting MS treatment, Briumvi®, listed on the PBS
The post New relapsing remitting MS treatment, Briumvi®, listed on the PBS appeared first on MS Australia. Source: www.msaustralia.org.au
Is it MS or something else? New research explains
The post Is it MS or something else? New research explains appeared first on MS Australia. Source: www.msaustralia.org.au
Bridging Science and Lived Experience: Reflections on the 2025 MS Progress in Research Conference
The post Bridging Science and Lived Experience: Reflections on the 2025 MS Progress in Research Conference appeared first on MS Australia. Source: www.msaustralia.org.au
6-week yoga program improves sleep, eases fatigue in people with MS
Taking part in a six-week yoga program improved self-reported physical activity and sleep quality, and reduced fatigue among people with multiple sclerosis (MS), according to a new study from Turkey. In a randomized clinical trial (NCT06128668), researchers assessed the benefits of yoga sessions, compared to no intervention, in 60 people with relapsing-remitting multiple sclerosis (RRMS),…
Motability
So I just thought I’d write a post to talk about something that I have to try and organise over … The post Motability appeared first on . Living with a Progressive Chronic illness…. New Meds, New House, New Feelings about My MS… My MS Life Update – June 2024 Source: trippingthroughtreacle.com
Developer granted patent in Japan for masitinib use in progressive MS
AB Science has received a patent in Japan covering the use of its investigational oral therapy masitinib for progressive forms of multiple sclerosis (MS). The new patent — JP 7788154 — grants the France-based pharmaceutical company protection in the Asian nation through February 2041 on the use of masitinib for both primary progressive MS (PPMS) and nonactive secondary…
Guest Post-The Missing Comparator
Tweet This is a guest post by @theMSguide who has multiple sclerosis. References supporting the view were supplied. Disclaimer: As ever for all posts. These are to be considered the views of the author only. Constructive comments, as ever, are welcomed The missing comparator: why MS drug risks are clear, but MS disease risks are…
Deanna Renee
The post Deanna Renee appeared first on MS Australia. Source: www.msaustralia.org.au